Results 21 to 30 of about 53,082 (276)

Uncomplicated percutaneous IVC filter removal following implantation time of 6033 days

open access: yesRadiology Case Reports, 2020
Most patients have a time limited indication for inferior vena cava filtration. When the indication has expired, a retrievable inferior vena cava filter should be removed percutaneously, unless the risks of retrieval outweigh the benefits.
Hans Michell, MD   +2 more
doaj   +1 more source

Dilemmas in anticoagulation and use of inferior vena cava filters in venous thromboembolism; a survey of Respiratory Physicians, Haematologists and Medical Oncologists and a review of the literature

open access: yesPulmonary Circulation, 2021
Twenty percent of patients with Cancer Associated Thrombosis receive an inferior vena cava filter annually. Insertion is guided by practice guidelines, which do not specify or discuss the use of inferior vena cava filters in malignancy.
Philip Craven   +4 more
doaj   +1 more source

Association of Inferior Vena Cava Filter Placement With Rates of Pulmonary Embolism in Patients With Cancer and Acute Lower Extremity Deep Venous Thrombosis

open access: yesJAMA Network Open, 2020
Key Points Question Is placement of an inferior vena cava filter associated with a lower rate of pulmonary embolism in patients with cancer and deep venous thrombosis?
S. Balabhadra   +10 more
semanticscholar   +1 more source

Inferior vena cava filters

open access: yesCanadian Medical Association Journal, 2015
Under fluoroscopic guidance, IVC filters are placed percutaneously via the jugular or femoral vein. Current guidelines recommend use in patients with known venous thromboembolism who have an absolute contraindication to anticoagulant therapy (e.g., patients with hemorrhagic stroke or ...
Sean A, Kennedy, Mark O, Baerlocher
openaire   +3 more sources

Inferior vena cava filter - comprehensive overview of current indications, techniques, complications and retrieval rates.

open access: yesVASA. Zeitschrift fur Gefasskrankheiten, 2020
Inferior vena cava (IVC) filter has been used to manage patients with pulmonary embolism and deep venous thrombosis. Its ease of use and the expansion of relative indications have led to a dramatic increase in IVC filter placement.
Xin Li   +7 more
semanticscholar   +1 more source

Case report: Endoluminal removal of a retrievable conical inferior vena cava filter with a ruptured retraction hook attached to the wall

open access: yesFrontiers in Surgery, 2022
We report the case of a patient who underwent endovascular retrieval of a conical inferior vena cava (IVC) filter with a ruptured retraction hook that was attached to the IVC wall.
Xuan Tian   +3 more
doaj   +1 more source

A Pericardial Pin

open access: yesJACC: Case Reports, 2021
A 39-year-old man presented with chest pain initially attributed to viral pericarditis. He was found to have an embolized inferior vena cava filter strut that perforated the right ventricle.
Kevin G. Buda, DO   +5 more
doaj   +1 more source

Procedural complications of inferior vena cava filter retrieval, an illustrated review

open access: yesCVIR Endovascular, 2020
Annually, approximately 65,000 inferior vena cava (IVC) filters are placed in the United States (Ahmed et al., J Am Coll Radiol 15:1553–1557, 2018). Approximately 35% of filters are eventually retrieved (Angel et al., J Vasc Interv Radiol 22: 1522–1530 ...
K. Quencer   +6 more
semanticscholar   +1 more source

Vena cava filters and inferior vena cava thrombosis [PDF]

open access: yesJournal of Vascular Surgery, 2007
Retrievable vena cava filters (R-VCF) are a recent addition to the therapeutic armamentarium for the prevention of pulmonary embolism. However, unlike permanent vena cava filters (P-VCF), outcomes data are limited regarding complication rates.This was a retrospective comparative analysis of consecutive patients undergoing placement of R-VCF vs P-VCF at
Matthew A, Corriere   +7 more
openaire   +2 more sources

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis

open access: yesHepatology, EarlyView., 2022
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Abstract Background and Aims Nucleotide‐binding oligomerization domain‐like receptor‐family pyrin domain‐containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis.
Jana Knorr   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy